HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Drug therapy of obesity].

Abstract
This review is dealing with currently available medications used in the treatment of obesity. Unfortunately currently available drugs did not prove effective in the long term treatment of obese patients. Fenfluramin and D-Fenfluramin has been withdrawn from the market because of severe side effects as pulmonary hypertension and valvular heart disease. Sibutramin, a serotonin noradrenalin reuptake inhibitor, will be available this year. Orlistat, an inhibitor of pancreatic lipases, has proven effective for weight reduction in obese patients. New drugs as alpha 2-adrenergic antagonists, cholecystokinin, neuropeptide y, bombesin and leptin are in the pipeline.
AuthorsJ G Wechsler
JournalActa medica Austriaca (Acta Med Austriaca) Vol. 25 Issue 4-5 Pg. 138-41 ( 1998) ISSN: 0303-8173 [Print] Austria
Vernacular TitleMedikamentöse Therapie der Adipositas.
PMID9879389 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Appetite Depressants
Topics
  • Animals
  • Appetite Depressants (adverse effects, therapeutic use)
  • Body Weight (drug effects)
  • Humans
  • Obesity (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: